129472003: Alemtuzumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\Immunosuppressant (substance)\Alemtuzumab

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunosuppressant (substance)\Alemtuzumab
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Alemtuzumab
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Alemtuzumab

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Alemtuzumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Alemtuzumab

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Alemtuzumab
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Alemtuzumab
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Alemtuzumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Alemtuzumab	Is a	agent antinéoplasique	false	Inferred relationship	Some
Alemtuzumab	Is a	Product containing monoclonal antibody (product)	false	Inferred relationship	Some
Alemtuzumab	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Alemtuzumab	Is a	anticorps monoclonal chimérique souris-humain d'isotype IgG	false	Inferred relationship	Some
Alemtuzumab	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Murine-human monoclonal immunoglobulin G antibody	false	Inferred relationship	Some
Alemtuzumab	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some
Alemtuzumab	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some
Alemtuzumab	Is a	Monoclonal antibody	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing alemtuzumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Alemtuzumab	Inferred relationship	Some	1
Alemtuzumab 30mg/3mL infusion concentrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Alemtuzumab	Inferred relationship	Some
MabCampath	Is a	False	Alemtuzumab	Inferred relationship	Some
Alemtuzumab 30mg/3mL infusion concentrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Alemtuzumab	Inferred relationship	Some
Alemtuzumab 30mg/mL infusion concentrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Alemtuzumab	Inferred relationship	Some
Product containing only alemtuzumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Alemtuzumab	Inferred relationship	Some	1
Alemtuzumab only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Alemtuzumab	Inferred relationship	Some	1
Alemtuzumab-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Alemtuzumab	Inferred relationship	Some	1
Product containing precisely alemtuzumab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Alemtuzumab	Inferred relationship	Some	1
Product containing precisely alemtuzumab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Alemtuzumab	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
208251015	Alemtuzumab	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
733608016	Alemtuzumab (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
54741000195117	alemtuzumab	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
189131000077113	alemtuzumab	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
69121000195118	Alemtuzumab	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module